We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0REU market cap is 409.19M. The company's latest EPS is DKK -0.0241 and P/E is -16.60.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.72M | -2.14M | -1.44M | -11.28M | -25.29M |
| Net Income | -14.42M | -32.88M | 5.39M | -9.44M | -24.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 72.4M | 57.58M | 63.65M | 21.52M | 81.34M |
| Total Liabilities | 5.24M | 23.3M | 21.08M | 2.61M | 42.4M |
| Total Equity | 67.16M | 34.28M | 42.57M | 18.91M | 38.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -274k | -9.91M | -2.09M | -8.3M | -16.62M |
| Investing | 1.65M | N/A | N/A | N/A | -73k |
| Financing | -1.38M | 9.9M | 2.09M | -278k | 17.06M |
| Market Cap | 409.19M |
| Price to Earnings Ratio | -16.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 97.56 |
| Price to Book Ratio | 10.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.02B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.40 |
| 52 Week Low | 0.40 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Pharma Equity Group A/s |
| Address |
vester farimagsgade 1, 2 copenhagen DK-2900 |
| Website | https://www.blue-vision.dk |
| Industry | money management (F34) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
